| RELATED PARTY TRANSACTIONS |
| 36. | RELATED PARTY TRANSACTIONS |
| a) | Apart
from the transactions detailed elsewhere in this financial information, the Group had no
transactions with related parties during the years ended December 31, 2023, 2024 and 2025. |
| b) | Transaction
with a related party
|
| | |
For the years ended December 31, | |
| | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
US$ | |
| | |
| | |
| | |
| |
| Dr. Zhai Yifan | |
| - | | |
| 29,533 | | |
| 4,223 | |
| Dr. Yang Dajun | |
| - | | |
| 3,933 | | |
| 562 | |
| | |
| - | | |
| 33,466 | | |
| 4,785 | |
| | | According to the HealthQuest Pharma Acquisition Agreement, a contingent consideration of RMB29,533 (US$4,223) due to Dr. Zhai was recognized during the year ended December 31, 2025. | | | | | | | | On 17 July 2025, the Company borrowed 22,000,000 ordinary shares of the Company from Dr. Yang to fulfil a placement to designated subscribers within the required timeline. The borrowed shares were returned to Dr. Yang on 29 July 2025 through the issuance of new shares, accompanied by a contractual borrowing cost payment of RMB 3,933, which was recorded as a reduction in equity in connection with such issuance. | | | | | | | c) | Outstanding balance with a related party |
| | |
As at December 31, | |
| | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
US$ | |
| | |
| | |
| | |
| |
| Other payables and accruals | |
| 29,344 | | |
| 10,308 | | |
| 1,474 | |
| Other non-current liabilities | |
| - | | |
| 6,374 | | |
| 911 | |
| | |
| | | |
| | | |
| | |
| Total for Dr. Zhai Yifan | |
| 29,344 | | |
| 16,682 | | |
| 2,385 | |
| | In accordance with the acquisition agreement, payable to Dr. Zhai Yifan represented the contingent consideration
related to the acquisition of Guangzhou HealthQuest Pharma Co., Ltd. |
| d) | Compensation of key management
personnel of the Group: |
| | For
the years ended December 31, |
| | |
| 2023 | | |
| 2024 | | |
| 2025 | | |
| 2025 | |
| | |
| RMB | | |
| RMB | | |
| RMB | | |
| US$ | |
| Short term employee benefits and fees | |
| 20,118 | | |
| 19,059 | | |
| 59,283 | | |
| 8,477 | |
| Equity-settled share-based payment expenses | |
| 1,763 | | |
| 625 | | |
| 3,141 | | |
| 449 | |
| Post-employment benefits | |
| 986 | | |
| 977 | | |
| 711 | | |
| 102 | |
| | |
| | | |
| | | |
| | | |
| | |
| Total | |
| 22,867 | | |
| 20,661 | | |
| 63,135 | | |
| 9,028 | |
|